Latest filing published 23 Jan 2024 for Protara Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jathin Bandari: trading record in brief
This profile gathers the share dealings of Jathin Bandari in Protara Therapeutics, Inc., where the filings describe the role as senior executive. Over a trading history stretching from 10 January 2022 to 19 January 2024, the count stands at 8 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 23 January 2024, the filings show a share grant worth €5,055 in Protara Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jathin Bandari
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 23,000 shares0Common StockSEC:0001213900-24-005726:0
- 2,879 shares@ US$1.9128.0% of flowCommon StockSEC:0001213900-24-005726:1
- 1,877 shares@ US$2.3922.8% of flowCommon StockSEC:0001213900-24-003334:0
- 682 shares@ US$2.468.5% of flowCommon StockSEC:0001213900-23-054759:0
- 20,700 shares0Common StockSEC:0001213900-23-004079:0
- 1,876 shares@ US$3.0029.1% of flowCommon StockSEC:0001213900-23-002260:0
- 682 shares@ US$3.2211.6% of flowCommon StockSEC:0001213900-22-037267:0
- 13,500 shares0Common StockSEC:0001209191-22-003084:0
8 of 8 declarations
